Skip to content

Clinical trials

Phase 3 Inflammation trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 3 Country / region: Brazil Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20101
20111
20121
20132
20141
20151
20181
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federal University of São Paulo2
Ache Laboratorios Farmaceuticos S.A.1
Azidus Brasil1
Federal University of Mato Grosso1
Federal University of Minas Gerais1
Hospital de Clinicas de Porto Alegre1
Instituto de Cardiologia do Rio Grande do Sul1
Instituto de Investigação em Imunologia1
National Institute of Allergy and Infectious Diseases (NIAID)1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation15
COVID-192
Myocardial Infarction2
Asthma1
Brain Death1
Bronchial Hyperreactivity1
Cardiovascular Diseases1
Cataract1
Common Cold1
Dyslipidemias1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.